Pancreatic carcinoma non-resectable
Information
- Disease name
- Pancreatic carcinoma non-resectable
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01593475 | Completed | Phase 2 | Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma | September 5, 2011 | December 31, 2016 |
| NCT00761345 | Completed | Phase 1 | Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer | September 2008 | February 2015 |
| NCT05642962 | Recruiting | Phase 1/Phase 2 | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | November 30, 2022 | November 30, 2024 |
| NCT02405585 | Terminated | Phase 2 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | April 2015 | July 30, 2016 |
| NCT01851174 | Terminated | Phase 2 | Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer | February 2013 | January 2015 |
| NCT01836432 | Terminated | Phase 3 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | May 2013 | March 24, 2017 |
| NCT01872377 | Terminated | N/A | Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer | July 2013 | May 16, 2018 |